Sigachi Industries Limited — Updates, 21-01-2026: Press Release
21-01-2026 | 11:09 am
21-01-2026 | 11:09 am
Sigachi achieved a major R&D milestone with new Cystic Fibrosis APIs, entering a high-value specialty segment. This development has an estimated annual revenue potential of ~₹250 Cr, leveraging a multi-billion dollar global market with long-term patent protection.
No comments yet. Be the first to comment!
